Why the study?
Despite robust trial evidence supporting EVAR for AAA repair, clinical practice varies and multiple areas require further elucidation.
Does endovascular aortic repair (EVAR) improve outcomes in patients with abdominal aortic aneurysm?
Does endovascular aortic repair (EVAR) improve outcomes in patients with abdominal aortic aneurysm?
This review highlights that EVAR is the current treatment of choice for most AAA patients, while identifying future research needs such as medical therapy roles and specific indications for women and the elderly.
Persistent practice variation in EVAR for AAA warrants caution; leaves open key areas requiring further prospective research.
During the last two decades, endovascular technology has revolutionized the management of patients with abdominal aortic aneurysm (AAA). Today, endovascular aortic repair (EVAR) is the treatment of choice for the majority of patients with an AAA. Randomized controlled trials provide robust evidence for the indication of AAA repair and the rationale for the use of EVAR in selected patients. However, despite that, practice varies and several areas need further elucidation. Important future challenges and areas of research include the role of medical therapy in AAA, whether the indication for repair should be any different in women and in the elderly, and long-term follow-up of patients undergoing complex EVAR with adjuncts, both for elective treatment and for ruptured AAA. Continuous rapid technical and clinical development is to be expected. In this paper, we review the current practice and evidence of stenting in AAA.
No takes yet. Share an insight, caveat, or question.
Steuer et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: